Our Company

Patrick Treacy, Antony Koblish and Adele Oliva saw a unique opportunity for one company to demonstrate leadership and set the agenda for innovation in surgical oncology. Founded in 2015, with best-in-class innovation partners, Onkos Surgical will deliver high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients. From modular segmental systems to customized solutions and patient specific products, Onkos Surgical will partner with surgeons to provide new innovations to help address complex cases.

Onkos Surgical has capabilities to increase the speed and delivery of innovation. Onkos Surgical is leveraging new technologies, such as 3D printing, to meet the unique needs of the cancer patient or surgeon. Onkos Surgical will develop products for both hard and soft-tissue applications while continuing to explore strategic partnerships to differentiate our product portfolio.

With great customer responsiveness, manufacturing lead-times and quality, our vision is to be able to service and support the needs of the surgical oncologist



At Onkos Surgical, we believe…
Individuals with cancer requiring surgery deserve solutions designed specifically for them. These individuals, their caregivers and their support network deserve an organization passionately championing their cause.

At Onkos Surgical, we exist…
To maintain a singular focus on surgical oncology by looking at everything we do through the lens of the cancer surgeon and their patients.

At Onkos Surgical, we will…

  • Find solutions to our patients’ unmet clinical needs and advocate for their cause.
  • Partner with surgical oncologists through research, education and innovation, to treat their patients more effectively and more efficiently.
  • Collaborate with regulatory agencies to find pathways to provide timely solutions while upholding the highest standards of quality or compliance.
  • Fulfill our employees’ desire to make a difference in the lives of the patients they serve while achieving their own professional growth.
  • Deliver value to our customers and shareholders.
Our Leadership

News & Press

Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis
Onkos Surgical Raises $15 Million in Series C Funding
Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surgery

Onkos Investors

1315 Capital

1315 Capital is a private investment firm with over $500 million under management that provides expansion and growth capital to commercial-stage medical technology, healthcare service, and specialty pharmaceutical companies.


Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

3D Systems

From digitization, design and simulation through manufacturing, inspection and management, 3D Systems’ comprehensive portfolio of technologies provides a seamless, customizable workflow designed to optimize products and processes while accelerating outcomes.